![]()
|
|
||||||||
J Biol Chem, Vol. 275, Issue 7, 4555-4560, February 18, 2000
From the Fhit, a member of the histidine triad superfamily
of nucleotide-binding proteins, binds and cleaves diadenosine
polyphosphates and functions as a tumor suppressor in human epithelial
cancers. Function of Fhit in tumor suppression does not require
diadenosine polyphosphate cleavage but correlates with the ability to
form substrate complexes. As diadenosine polyphosphates are at lower cellular concentrations than mononucleotides, we sought to quantify interactions between Fhit and competitive inhibitors with the use of
diadenosine polyphosphate analogs containing fluorophores in place of
one nucleoside.
Appp-S-(7-diethylamino-4-methyl-3-(4-succinimidylphenyl)) coumarin (ApppAMC),
Appp-S-(4-4-difluoro-5,7-dimethyl-4-bora-3a,4a-diaza-s-indacine-3-yl) methylaminoacetyl (ApppBODIPY), and GpppBODIPY, synthesized in high yield, are effective Fhit substrates, producing AMP or GMP plus
fluorophore diphosphates. GpppBODIPY cleavage is accompanied by a
5.4-fold increase in fluorescence because BODIPY fluorescence is
quenched by stacking with guanine. Titration of unlabeled diadenosine polyphosphates, inorganic pyrophosphate, mononucleotides, and inorganic
phosphate into fluorescent assays provided values of Km and KI as competitive
inhibitors. The data indicate that Fhit discriminates between good
substrates via kcat and against cellular
competitors in equilibrium binding terms. Surprisingly, pyrophosphate
competes better than purine mononucleotides.
Fhit-nucleotide Specificity Probed with Novel Fluorescent and
Fluorogenic Substrates*
§,
,
Kimmel Cancer Center, Thomas Jefferson
University, Philadelphia, Pennsylvania 19107, and ¶ Molecular
Probes, Eugene, Oregon 97402
*
This work was supported by National Institutes of Health NCI
Research Grant CA75954 (to C. B.), a National Institutes of Health NCI institutional training grant (to A. D.), and new investigator awards from the March of Dimes Birth Defects Foundation, the Burroughs Wellcome Fund, and the Arnold and Mabel Beckman Foundation (to C. B.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Kimmel Cancer
Center, Thomas Jefferson University, 233 S. Tenth St., Rm. 826, Philadelphia, PA 19107. Tel.: 215-503-4573; Fax: 215-923-1696; E-mail:
brenner@dada.jci.tju.edu.
This article has been cited by other articles:
![]() |
T. Takahashi, M. Tada, S. Igarashi, A. Koyama, H. Date, A. Yokoseki, A. Shiga, Y. Yoshida, S. Tsuji, M. Nishizawa, et al. Aprataxin, causative gene product for EAOH/AOA1, repairs DNA single-strand breaks with damaged 3'-phosphate and 3'-phosphoglycolate ends Nucleic Acids Res., June 28, 2007; 35(11): 3797 - 3809. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Kijas, J. L. Harris, J. M. Harris, and M. F. Lavin Aprataxin Forms a Discrete Branch in the HIT (Histidine Triad) Superfamily of Proteins with Both DNA/RNA Binding and Nucleotide Hydrolase Activities J. Biol. Chem., May 19, 2006; 281(20): 13939 - 13948. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. F. Seidle, P. Bieganowski, and C. Brenner Disease-associated Mutations Inactivate AMP-Lysine Hydrolase Activity of Aprataxin J. Biol. Chem., June 3, 2005; 280(22): 20927 - 20931. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Murakoshi, R. Iino, T. Kobayashi, T. Fujiwara, C. Ohshima, A. Yoshimura, and A. Kusumi Single-molecule imaging analysis of Ras activation in living cells PNAS, May 11, 2004; 101(19): 7317 - 7322. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Krakowiak, H. C. Pace, G. M. Blackburn, M. Adams, A. Mekhalfia, R. Kaczmarek, J. Baraniak, W. J. Stec, and C. Brenner Biochemical, Crystallographic, and Mutagenic Characterization of Hint, the AMP-Lysine Hydrolase, with Novel Substrates and Inhibitors J. Biol. Chem., April 30, 2004; 279(18): 18711 - 18716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Korlach, D. W. Baird, A. A. Heikal, K. R. Gee, G. R. Hoffman, and W. W. Webb Spontaneous nucleotide exchange in low molecular weight GTPases by fluorescently labeled {gamma}-phosphate-linked GTP analogs PNAS, March 2, 2004; 101(9): 2800 - 2805. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Kwasnicka, A. Krakowiak, C. Thacker, C. Brenner, and S. R. Vincent Coordinate Expression of NADPH-dependent Flavin Reductase, Fre-1, and Hint-related 7meGMP-directed Hydrolase, DCS-1 J. Biol. Chem., October 3, 2003; 278(40): 39051 - 39058. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Trapasso, A. Krakowiak, R. Cesari, J. Arkles, S. Yendamuri, H. Ishii, A. Vecchione, T. Kuroki, P. Bieganowski, H. C. Pace, et al. Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding PNAS, February 18, 2003; 100(4): 1592 - 1597. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Bieganowski, P. N. Garrison, S. C. Hodawadekar, G. Faye, L. D. Barnes, and C. Brenner Adenosine Monophosphoramidase Activity of Hint and Hnt1 Supports Function of Kin28, Ccl1, and Tfb3 J. Biol. Chem., March 22, 2002; 277(13): 10852 - 10860. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yoshida, T. Sawada, H. Ishii, R. E. Gerszten, A. Rosenzweig, M. A. Gimbrone Jr, Y. Yasukochi, and F. Numano HMG-CoA Reductase Inhibitor Modulates Monocyte-Endothelial Cell Interaction Under Physiological Flow Conditions In Vitro : Involvement of Rho GTPase-Dependent Mechanism Arterioscler. Thromb. Vasc. Biol., July 1, 2001; 21(7): 1165 - 1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Bennett, T. A. Key, V. V. Gurevich, R. Neubig, E. R. Prossnitz, and L. A. Sklar Real-time Analysis of G Protein-coupled Receptor Reconstitution in a Solubilized System J. Biol. Chem., June 15, 2001; 276(25): 22453 - 22460. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |